 |
|
October 27, 2025 |
| Covering
Life Sciences Drugs, Diagnostics,
Devices, Digital Health |
|
|
|
* may need subscription to view |
- Actinium Pharmaceuticals: New Data
Demonstrating Potent and Durable Efficacy of
ATNM-400, a First-in-Class Multi-Tumor
Actinium-225 Radiotherapy, at the 32nd Annual
Prostate Cancer Foundation Scientific Retreat
More
- Amarin: Statement Supporting FDA’s Action to
Revise Labeling for Fenofibrate Drugs
Reinforcing a Lack of Cardiovascular Benefit More
- Amneal: Launches Brekiya – the First and
Only DHE Autoinjector for Adults With Migraine
With or Without Aura and Cluster Headaches
More
- Bayer: Lynkuet (elinzanetant), the
First and Only Neurokinin 1 and Neurokinin 3
Receptor Antagonist, Receives FDA Approval
for Moderate to Severe Hot Flashes Due to
Menopause More
More
More*
More*
- Bristol Myers Squibb: Encouraging Data From
Phase 1 Breakfree-1 Study of CD19 NEX-T CAR T
Cell Therapy in Three Chronic Autoimmune
Diseases at ACR Convergence 2025 More
- Bristol Myers Squibb: Two Late-Breaking
Presentations Demonstrating Sotyktu
(deucravacitinib) Efficacy in Psoriatic
Arthritis and Systemic Lupus Erythematosus More
- IN8bio: T cell Engager Data Demonstrating
Deep B Cell Depletion for Autoimmune
Indications
More
- Merck: U.S. FDA Approves Updated Indication
for WINREVAIR (sotatercept-csrk) in Adults
With Pulmonary Arterial Hypertension (PAH,
WHO* Group 1 Pulmonary Hypertension) Based on
Phase 3 ZENITH Study More
- Organon: Appoints Company Executive
Joseph Morrissey as Interim CEO and Board
Chair Carrie Cox as Executive Chair; Results
of Audit Committee Investigation More
- Phathom Pharmaceuticals: Publication of Data
From Phase 3 pHalcon-NERD-301 Study Showing
VOQUEZNA (vonoprazan) Improved Nocturnal GERD
Symptoms in Patients With Non-Erosive Reflux
Disease More
- PMV Pharmaceuticals: Updated Rezatapopt
Monotherapy Interim Data From Ongoing PYNNACLE
Phase 2 Trial Across Multiple Solid Tumors
With a TP53 Y220C Mutation More
- Syndax: FDA Approval of Revuforj (revumenib)
in Adult and Pediatric Patients With Relapsed
or Refractory NPM1 Mutated Acute Myeloid
Leukemia More
More
- Tonix Pharmaceuticals: Data on Tonmya
(Cyclobenzaprine HCl Sublingual Tablets) at
the 2025 American College of Rheumatology
(ACR) Convergence More
- UroGen: Centers for Medicare and Medicaid
Services Assigns Permanent J Code for ZUSDURI
Effective January 1, 2026 More
- Whitehawk Therapeutics: Real-World Analysis
Confirming PTK7 as a Broadly Expressed,
Clinically Relevant Target Across Solid Tumors
at AACR-NCI-EORTC More
|
|
 |
-
- Enzon and Viskase: Amendment to Merger
Agreement More
- Exclusive
VC Funding Data from BYTE51, with Special
Big4Bio Pricing
More
- Hovione: Completes Initial $100M
Investment Cycle to Expand U.S. Operations
at New Jersey Manufacturing Site More
|
|
- BioPharmGuy News: Peekaboo Poo, The
Humblest, Edit for Type O's, Dumb Plumbum,
Team Roast More
- Biotech Hangout: Episode 160 Podcast
- More on Genomic Prediction Suing Nucleus
Genomics, Former Employees for Theft of Trade
Secrets More*
- Subscribe to LifeSci Startup for
Updates on US Startups More
|
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: NYC Life Science Company
Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
Feature your company |
|
Apply to have your company
showcased by Big4Bio. |
|
|
|
|
|
 |
| Elevating
Executive Presence: A Blueprint
for Life Sciences and Biotech
Leaders |
|
Learn More
→ |
|
|
- CEO's Perspective: Big Moves Come with Big
Responsibilities More
- CEO's Perspective: The High Cost of Job
Hopping More
- 8 Companies Hiring Now in Regulatory More
- ICYMI: The Power of Peer Learning: Why Even
Top Biotech Leaders Need Mentorship More
- Novo Nordisk Lines Up Corporate Affairs
Exec, Overshadowed by Board Drama More*
- Q3 Layoffs Up 280% YOY With CSL, Merck,
Novo’s Restructurings More
- What’s Next in Precision Medicine:
Leadership Challenges and Opportunities More
|
|
Event
Center
|
Note:
Events may be in any Big4Bio region or
virtual |
|
- Biocom California CEO Summit (Los
Angeles)
Oct 29
- 15th Annual PODD Conference Oct
27-28
- New Jersey Life Sciences & Biotech
Conference Oct
28
- Pantheon 2025
Nov 6
- BIO-Europe
2025 Nov
11-12
- Copay,
Reimbursement and Access Congress (Save 10%
with VIP code: 25B4B10) Nov
18-20
- Pharma/Biotech
Gross-To-Net Summit (Save 10% with VIP code:
25B4B10) Nov
18-20
- Patient
Support Services Congress (Save 10% with VIP
code: 25B4B10) Nov
20-21
- Compounding
Pharmacy Compliance (Save 10% with VIP code:
25B4B10) Dec
9-10
- Trade
and Channel Strategies (Save 10% with VIP
code: 25B4B10) Dec
9-11
- Advancing
Drug Development Forum Dec
11
|
SEE FULL
EVENT SCHEDULE AT THE BIOCALENDAR
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:NYC,
all rights reserved 2025
© 2025
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
